long intergenic non-protein coding RNA 1739Genealiases: []
Q-omics provides the consensus-scored LINC01739 profile across patient tissues and cancer cell-line models. LINC01739 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, LINC01739 is differentially expressed in 2, with the highest sampling consensus in KIRC. Additionally, LINC01739 RNA expression shows 8,726 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight THCA, KIRC, and COAD as cancer lineages where LINC01739 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01739 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01739 survival associations across molecular data types. LINC01739 RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01739 RNA expression–survival associations across cancer types. High LINC01739 expression shows unfavorable associations in THCA, STAD, READ, LIHC, LGG and COAD. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for LINC01739 RNA expression.
This table summarizes LINC01739 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01739. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01739 shows lower tumor expression in KIRC and KIRP. The KIRC box plot shows higher LINC01739 RNA expression in normal versus tumor tissue (log2 FC = −0.549, t-test p < 0.001).
This table shows molecular features associated with LINC01739 in patient tissues and cancer cell lines. In patient samples, LINC01739 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
